The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback